Metronidazole IV is an isotonic formulation, composed of a superior grade of injectable metronidazole specially developed by Unique's R&D division in India, for intravenous administration in susceptible life threatening infections.
It is particularly suited for patients who cannot retain oral medication and for patients in whom desired serum concentrations have to be attained rapidly and reliably. Metronidazole IV is thus indicated for Treatment of infections caused by Bacteroides fragilis and other species of Bacteroides like Fusobacteria, Eubacteria and Anaerobic cocci such as Intra abdominal infections: appendicitis, cholecystitis, peritonitis, liver abscess and post-operative wound infection.
Gynecological and obstetrical infections: puerperal sepsis, pelvic pellulitis, pelvic peritonitis.
Respiratory infections: necrotising pneumonia, empyema, and lung abscess.
Central nervous system injections: meningitis, brain abscess.
Miscellaneous infections: septicemia, gas gangrene, osteomyelitis.
Prevention of post operative infections due to anaerobic bacteria.
Treatment of amoebic abscess of the liver and in moribund or toxic cases of fulminating intestine.